What is the role of aztreonam-avibactam in treating infections caused by NDM-producing bacteria?

Aztreonam-avibactam is a promising treatment option for NDM-producing bacterial infections, demonstrated to have strong in vitro activity and fulfilling an unmet need by targeting resistant strains. Clinical studies are needed to confirm its effectiveness in practice.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24287135
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What is the role of aztreonam-avibactam in treating infections caused by NDM-producing bacteria?

Tripdatabase
5 links
Zenodo (CERN European Organization for Nuclear Research)
Antibiotic Resistance in Bacteria
article

What is the role of aztreonam-avibactam in treating infections caused by NDM-producing bacteria?

Tripdatabase
article en

Abstract

Aztreonam-avibactam is a promising treatment option for NDM-producing bacterial infections, demonstrated to have strong in vitro activity and fulfilling an unmet need by targeting resistant strains. Clinical studies are needed to confirm its effectiveness in practice.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon